Home
>
National Drug Code (NDC)
>
ETODOLAC
ETODOLAC - 67296-0595-1 - (etodolac)
Drug Information of ETODOLAC
| Product NDC: | 67296-0595 |
| Proprietary Name: | ETODOLAC |
| Non Proprietary Name: | etodolac |
| Active Ingredient(s): | 400 mg/1 & nbsp; etodolac |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ETODOLAC
| Product NDC: | 67296-0595 |
| Labeler Name: | RedPharm Drug Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074819 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20081201 |
Package Information of ETODOLAC
| Package NDC: | 67296-0595-1 |
| Package Description: | 15 TABLET, FILM COATED in 1 BOTTLE (67296-0595-1) |
NDC Information of ETODOLAC
| NDC Code | 67296-0595-1 |
| Proprietary Name | ETODOLAC |
| Package Description | 15 TABLET, FILM COATED in 1 BOTTLE (67296-0595-1) |
| Product NDC | 67296-0595 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etodolac |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20081201 |
| Marketing Category Name | ANDA |
| Labeler Name | RedPharm Drug Inc. |
| Substance Name | ETODOLAC |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
